Key facts
- This page summarizes Pablo J. Cagnoni's Form 4 filing for INCYTE CORP (INCY).
- 10 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2026, 16:04.
Pablo J. Cagnoni - 15 Sep 2026 Form 4 Insider Report for INCYTE CORP (INCY)
- Reporting relationship
- President, Global Head of R&D
- Issuer ticker
- INCY
- Reported as of
- 15 Sep 2026
- Net transaction value
- -$2,797,629
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 16:04:37 UTC
- Prior SEC filing
- 20 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Pablo J. Cagnoni filed Form 4 for INCYTE CORP (INCY) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 20 Aug 2026.
- Current net transaction value: -$2,797,629.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001205703
Primary reporting owner
CAGNONI PABLO J
- Relationship
- President, Global Head of R&D
- Address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON
- Signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INCY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +2,957
- Change %
- +1.6%
- Price
- $61.76*
- Shares after
- 186,157
- Date
- 15 Sep 2026
- Ownership
- Direct
INCY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,551
- Change %
- +2.4%
- Price
- $61.18*
- Shares after
- 190,708
- Date
- 15 Sep 2026
- Ownership
- Direct
INCY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,477
- Change %
- +3.4%
- Price
- $64.25*
- Shares after
- 197,185
- Date
- 15 Sep 2026
- Ownership
- Direct
INCY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +9,233
- Change %
- +4.7%
- Price
- $71.93*
- Shares after
- 206,418
- Date
- 15 Sep 2026
- Ownership
- Direct
INCY
transaction
Common Stock
Sale
- Transaction value
- $1,112,576
- Shares
- -9,233
- Change %
- -4.5%
- Price
- $120.50
- Shares after
- 197,185
- Date
- 15 Sep 2026
- Ownership
- Direct
INCY
transaction
Common Stock
Sale
- Transaction value
- $1,685,053
- Shares
- -13,985
- Change %
- -7.1%
- Price
- $120.49
- Shares after
- 183,200
- Date
- 15 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -2,957
- Change %
- -41%
- Price
- $0.000000*
- Shares after
- 4,225
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,957
- Exercise price
- $61.76
- Footnotes
- F2
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -4,551
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 4,551
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,551
- Exercise price
- $61.18
- Footnotes
- F3
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -6,477
- Change %
- -24%
- Price
- $0.000000*
- Shares after
- 20,356
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,477
- Exercise price
- $64.25
- Footnotes
- F4
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -9,233
- Change %
- -33%
- Price
- $0.000000*
- Shares after
- 18,466
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,233
- Exercise price
- $71.93
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
Footnote F2
The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Footnote F3
Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.
Footnote F4
The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Footnote F5
Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.